Full history for every metric is available with a Kvantra account
Key financial summary
Financials in CHF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CHF m | 3,480 | 3,835 | 4,014 | 3,746 | 3,921 | 4,136 | 4,277 | 4,390 |
| Operating profit | CHF m | 223 | 204 | ||||||
| Net profit | CHF m | 172 | 168 | 165 | 174 | 183 | 181 | 159 | 189 |
| EPS reported | CHF | 3.63 | 3.19 | ||||||
| Operating cashflow per share | CHF | 6.01 | 5.04 | ||||||
| Capex per share | CHF | 0.55 | 0.63 | ||||||
| FCF per share | CHF | 5.46 | 4.41 | ||||||
| Free cash flow | CHF m | 272 | 220 | ||||||
| Net debt | CHF m | 701 | 858 | ||||||
| Book value equity | CHF m | 1,482 | 1,412 | ||||||
| Book value per share | CHF | 29.71 | 28.30 | ||||||
| Number of shares | m | 49.89 | 49.89 | ||||||
| DPS (TTM paid) | CHF | 2.50 | 2.50 |
Financial summary
Financials in CHF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 26.91 | - | ||||||
| P/B LTM | x | 3.29 | 3.02 | ||||||
| P/S LTM | x | 1.18 | 1.00 | ||||||
| P/FCF LTM | x | 17.88 | 19.36 | ||||||
| EV/EBITDA LTM | x | 17.15 | 14.67 | ||||||
| EV/Sales LTM | x | 1.41 | 1.20 | ||||||
| Earnings Yield LTM | % | 3.72% | 3.73% | ||||||
| FCF Yield | % | 5.59% | 5.16% | ||||||
| Quality | |||||||||
| ROE | % | 12.22% | 11.00% | ||||||
| ROIC | % | 7.47% | 6.44% | ||||||
| Operating margin | % | 5.39% | 4.78% | ||||||
| Gross margin | % | 10.37% | 9.86% | ||||||
| FCF/Sales | % | 6.59% | 5.14% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -1.09% | -17.36% | ||||||
| Sales Growth YoY | % | +5.47% | +6.48% | ||||||
| Net Income Growth YoY | % | -1.01% | -17.24% | ||||||
| FCF Growth | % | +41.60% | -26.21% | ||||||
| Operating Profit Growth | % | +9.01% | -4.32% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 2.36% | 2.92% | ||||||
| Dividend Growth | % | +8.70% | +8.70% | ||||||
| Payout Ratio | % | 63.57% | 63.56% | ||||||
| FCF/Debt | x | 0.26 | 0.20 | ||||||
| Net Debt/EBITDA | x | 2.79 | 3.12 | ||||||
| EBIT/Net interest | x | 14.24 | 13.89 | ||||||
| Net debt/market cap | % | 14.40% | 20.13% | ||||||
| Net debt/Equity | x | 0.47 | 0.61 | ||||||
| Gross debt/equity | x | 0.72 | 0.80 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Based on consensus from external analysts. Not Kvantra's opinion.
Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free